Results: BYOT

Search articles by EPIC code
EPIC BYOT
views

Byotrol – argues “a significant improvement in product sales”, but what about the overall performance?...

A trading update from infection prevention and control-focused company Byotrol (BYOT) commences, “Our second half performance (six months to 31 March 2022) is showing a significant improvement in product sales compared to our first half, and the order book remains strong into year end” and includes “if we do not conclude any large IP sales, we would expect overall revenues to be no less than £6m, with positive underlying EBITDA for the year… we expect our cash position at year end to be no less than £1m”. The shares have currently responded up to 3.15p, but what of they still down from above 5p as recently as December?...

Page 1 of 1 (10 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments